GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NewAmsterdam Pharma Co NV (FRA:KH6) » Definitions » Institutional Ownership

NewAmsterdam Pharma Co NV (FRA:KH6) Institutional Ownership : 2.76% (As of May. 15, 2024)


View and export this data going back to 2022. Start your Free Trial

What is NewAmsterdam Pharma Co NV Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, NewAmsterdam Pharma Co NV's institutional ownership is 2.76%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, NewAmsterdam Pharma Co NV's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, NewAmsterdam Pharma Co NV's Float Percentage Of Total Shares Outstanding is 49.17%.


NewAmsterdam Pharma Co NV Institutional Ownership Historical Data

The historical data trend for NewAmsterdam Pharma Co NV's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NewAmsterdam Pharma Co NV Institutional Ownership Chart

NewAmsterdam Pharma Co NV Historical Data

The historical data trend for NewAmsterdam Pharma Co NV can be seen below:

2023-04-30 2023-05-31 2023-06-30 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-03-31
Institutional Ownership 0.28 0.29 0.33 0.41 0.42 0.44 0.73 1.52 1.76 2.76

NewAmsterdam Pharma Co NV Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


NewAmsterdam Pharma Co NV (FRA:KH6) Business Description

Traded in Other Exchanges
Address
Gooimeer 2-35, Naarden, NH, NLD, 1411 DC
NewAmsterdam Pharma Co NV is a clinical-stage company focused on the research and development of transformative therapies for metabolic diseases and Alzheimer's disease.

NewAmsterdam Pharma Co NV (FRA:KH6) Headlines

No Headlines